शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
GPTHEALTHNSEGPT Healthcare Limited· Healthcare ServicesHighNeutral
Announced Fri, 23 May, 2025 · 17:16 IST

GPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

GPTHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.2%Reaction day
₹155.90
prior close
₹154.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-2.7% vs market
Hospital peers, median of 19sector+0.3%-2.5% vs sector

On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 2.5 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.4
10m
+0.3
15m
+0.8
30m
+1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.2+0.6-2.7+0.3-2.5
Next day
-2.0+0.5-2.5-0.5-1.5
2d
-1.9+0.8-2.7-0.3-1.6
3d
-1.9+1.2-3.0-1.2-0.7
4d
-1.9+1.5-3.3-0.2-1.7
5d
-2.5+1.6-4.1-0.4-2.1
1w
-3.6+1.8-5.4-0.9-2.7
15d
-1.9+3.3-5.1+0.3-2.2
1m
-6.4+3.1-9.5+0.8-7.1
2m
+2.3+2.3-0.0+10.5-8.3
3m
-2.8+0.2-3.0+10.2-13.0
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 19Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

GPT Healthcare Limited has filed its financial results with the NSE for the quarter and financial year ended March 31, 2025. The submitted document is the company's audited/full-year financial performance report for FY25. Specific revenue, profit, and margin figures were not included in the announcement text and would need to be reviewed from the detailed results filing. Investors should look at the accompanying financial statements for actual performance numbers.

Likely market impact

This is a routine regulatory filing confirming submission of FY25 results; actual stock or shareholder impact will depend on the numbers in the detailed results, which were not provided in the announcement.